相关实验视频

Updated: Jul 2, 2025

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis

Published on: March 9, 2015

脂质相关代谢物对雄激素脱发的因果作用:孟德尔的随机化研究

Lingbo Bi¹, Chaofan Wang¹, Yimei Du¹

¹Department of Dermatology, Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, People's Republic of China.

Clinical, cosmetic and investigational dermatology

|February 19, 2024

概括

脂肪含量升高,包括阿波利波蛋白B (ApoB),低密度脂蛋白 (LDL) 和非常低密度脂蛋白 (VLDL),因果性地增加了雄激素脱发症 (AGA) 的风险. 这一发现表明,脂质代谢和脱发之间存在直接联系.

科学领域:

代谢研究的研究.
皮肤病学皮肤病学
遗传学是一个遗传学.

背景情况:

雄激素性脱发症 (AGA) 是一种常见的脱发形式,具有复杂的促成因素.
脂类相关代谢物 (LRM) 在各种生理过程中起着至关重要的作用.
在LRMs和AGA之间潜在的因果关系仍未完全阐明.

研究的目的:

调查脂质相关代谢物 (LRMs) 的水平增加和雄激素脱发症 (AGA) 的发展之间的潜在因果关系.

主要方法:

采用了两个样本的门德尔随机化 (MR) 研究设计.
与9个LRM相关的单核酸多态 (SNP) 从全基因组关联研究 (GWAS) 数据集中确定.
为了评估因果关系,进行了MR分析,特别是使用固定效应逆方差加权 (IVW) 方法.

主要成果:

核磁共振分析显示,阿波蛋白B (ApoB),低密度脂蛋白 (LDL) 和非常低密度脂蛋白 (VLDL) 的水平升高与AGA风险增加之间存在显著的因果关系.
没有检测到显著的异质性或质性,这支持了研究结果的稳定性.
结果表明,特定脂质代谢物与AGA发生率之间存在直接的因果关系.

结论:

血清中ApoB,LDL和VLDL水平的升高与患上雄激素脱发症的风险显著增加有关.
这种已确定的因果关系是强大的,不会被其他遗传或环境因素所混.
这些发现强调了脂质新陈代谢在AGA的发病过程中的重要性,这表明了潜在的治疗点.

关键词:

这就是为什么LDL,LDL是LDL.这是VLDLDL.安卓质脱发症 (androgenic alopecia) 是一种亚脂蛋白B是阿波利波蛋白B的一种.

更多相关视频

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

相关概念视频

Overview of Lipid Metabolism

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...

Mutagenicity and Carcinogenicity

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...

Lipid-derived Compounds in the Human Body

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...

Factors Affecting Drug Biotransformation: Biological

Factors Affecting Drug Biotransformation: Biological

Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...